– UK, London – Thorn Medical PLC, the international healthcare group, today announces the appointment of Lord Beaverbrook to the Board, with immediate effect.
From 2000 to 2007 he was Chairman of Net Integration Technologies Inc. of Toronto, now part of IBM. He is currently Chairman of Cherif Investment Properties Limited and a Director of Ansgate Barnes Holdco Limited, a property development company.
Prior to that, Lord Beaverbrook was a Lord in Waiting and Government Whip (1986-1988) and the Treasurer of the Conservative Party and the European Democrat Union (1990-1992).
In 1983 he founded and served as Chairman of VenTech Healthcare Corporation, which acquired Abbey Medical Inc., the then largest supplier of home healthcare equipment in the USA. In 1995, Lord Beaverbrook founded MARK Telecom, one of the first of the new ‘switchless re-sellers’ in the UK. This interest in the Telecom industry led to the formation of Highway One AG, a broadband, multimedia and data transport company of which he was Chairman until 1999 prior to it being sold to Telefonica in 2001.
From 1972 to 1978 Lord Beaverbrook worked for Beaverbrook Newspapers, starting as a management trainee and ultimately rising to General Manager of the Sunday Express. Since 1978 he has served as a director of the Aitken/Beaverbrook Family Office, overseeing a diversified investment fund, specialising in real estate for many years, and, more recently, in oil and gas, and insurance.
He became Honorary Air Commodore of 4624 (County of Oxford) Movements Squadron Royal Auxiliary Air Force in July 2004, and in October 2009 was appointed Honorary Inspector General, Royal Auxiliary Air Force in the rank of Air Vice-Marshal.
Jack Kaye, Thorn Medical’s Chairman and Chief Executive, said: “We’re delighted to welcome Lord Beaverbrook back to the Board as non-executive director. His international operations experience in the medical and technology fields will be a great help to achieving our challenging global expansion plans now that he has more time to devote to assisting us again.”
Lord Beaverbrook added, “I regretted having to leave Thorn Medical to devote my time to other matters, but am glad to be re-joining the Board now in the run-up to our imminent stock market listing which will be the springboard for significant growth in the year ahead.”
Thorn Medical PLC
Thorn Medical is a trusted expert investor and acceleration partner dedicated to breaking down the barriers to providing more efficient and effective healthcare worldwide.
With a clear focus on improving human wellbeing, it acts as an aggregator of innovative, scientifically-validated medical technology, pharmaceutical products and healthcare services businesses.
It aims to transform organisational performance through delivering best practice flexible management services that streamline operations, reduce costs, encourage cross-fertilisation, expand market reach and enhance return on capital.
Thorn Medical is dedicated to this market, with a global perspective and an understanding at first hand of the evolving challenges that healthcare businesses face in growing successfully.
Thorn Medical understands how to create value for investors, service providers and patients through building a balanced portfolio of pre-and post-revenue companies that specialise in commercialising innovative and medical technologies and services.
Thorn Medical will continue to grow both organically and through acquisitions, continually developing the enterprise and fully addressing the human health cycle and its genetic, environmental, physical and nutritional influencing factors.
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
Comments are closed.